Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study

NCT02509481 is registered in ClinicalTrials.gov with Colorado State University as lead sponsor.

NCT NCT02509481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02509481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study
Lead sponsor
Colorado State University
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2015
Completion date
December 31, 2015
Enrollment
2,712 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic filariasis, malaria